Ninety-one consecutive pneumococcal isolates (primarily from sputum), recovered in Chongqing Southwest Hospital during a 12 month period in 2009-2010 from individuals of all ages with suspected cases of pneumococcal disease, were subjected to PCR-serotyping, Quellung reaction serotyping, antimicrobial-susceptibility testing and multilocus sequence typing (MLST). Although 20 different serotypes were observed, most isolates (69, 75.8 %) were of serotypes included in the pneumococcal 13-valent conjugate vaccine (PCV13), including 33 of the 46 (71.7 %) isolates recovered from individuals less than 5 years of age. The prevalent serotypes were 19F (34 %), 19A (9.9 %), 6B (9.9 %), 23F (7.7 %), 14 (6.6 %) and 6A (4.4 %). PCR-determined serotypes were in agreement with Quellung testing, with the exception of two serotype 33C isolates. Most or all isolates within each PCV13 serotype were represented by one genotype, with the globally disseminated MLST sequence types (STs) ST271, ST320, ST90 and ST81 each accounting for the highly resistant isolates within serotypes 19F, 19A, 6B and 23F, respectively. Sixty-six (72.5 %) isolates were resistant to combinations of b-lactam antibiotics (BLAs). A total of 63 of these 66 (95.5 %) BLA-resistant isolates were of serotypes included in PCV13; however, 3 serogroup 15 isolates were also BLA-resistant. Most isolates (88/91596.7 %) were resistant to erythromycin and clindamycin. The majority of isolates were also resistant to tetracycline (76, 84 %) and to cotrimoxazole (67, 74 %). This work revealed that the majority of antimicrobial-resistant isolates (50/91554.9 %) recovered in this Chinese hospital were represented by four global clones. Serotypes for these as well as more obscure strains were readily determined by using PCR.
INTRODUCTION
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia and has been estimated to cause approximately 800 000 deaths per year in children ,5 years of age, with the majority of these deaths due to pneumonia in developing countries (O'Brien et al., 2009) . Pneumococcal serotype distribution analysis from large coastal population centres in China for the period of [2006] [2007] [2008] showed that four 7-valent conjugate vaccine (PCV7) serotypes and the 13-valent conjugate vaccine (PCV13) type 19A were the five most common serotypes recovered from children hospitalized with pneumonia (Yao et al., 2011) . This work also revealed that these pneumococcal conjugate vaccine (PCV) serotypes encompassed the majority of antimicrobial-resistant pneumococcal isolates.
Fortunately, the pneumococcal PCV7 became available for the Chinese private sector in September of 2008.
To encourage the introduction and successful utilization of highly effective PCVs, it is important to reveal serotype distributions of prevalent pneumococcal strains. Serotyping pneumococci using the traditional Quellung method requires considerable specialized technical expertise and expensive typing reagents. In comparison, PCRbased serotyping only requires basic conventional PCR capability, is relatively inexpensive, and appears to be reliable for most pneumococcal isolates recovered from diverse locations and settings (Carvalho et al., 2010; Dias et al., 2007; Morais et al., 2007; Pai et al., 2006) . Here we directly compared PCR serotyping to Quellung testing of 91 pneumonia-associated isolates recovered within a single hospital in central China. We also determined antimicrobial-susceptibility patterns to assess whether resistant disease-causing strains would likely be targeted by existing PCVs. Finally, we performed multilocus sequence typing (MLST) of the isolates for comparison with genotypes IP: 54.70.40.11
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METHODS
Isolates. This project was approved by the Director of Chongqing Southwest Hospital. All isolates were recovered during the course of routine patient care. Patient identifiers were not provided, with the only information provided being patient ages (in years), specimen sources and dates of collection. Between March 2009 and March 2010, 91 pneumococcal isolates (Table 1) were consecutively isolated from clinical specimens of patients of all ages at Chongqing Southwest Hospital. Chongqing is situated in South-West China and has a population of more than 31 million. Eighty-one of the isolates were recovered from sputum samples from individuals hospitalized with pneumonia. For older individuals, cough sputum specimens were obtained. For infants and young children, sputum specimens were obtained using a nasal-pharyngeal aspirator connected to a mucous trap. The 10 remaining isolates were recovered from blood (three isolates), cerebrospinal fluid (two isolates), pleural fluid (one isolate), eye secretion (three isolates) and the throat (one isolate).
Serotype determination. Isolates were serotyped by latex agglutination and the Quellung reaction using typing antisera prepared in the Streptococcus Laboratory, Centers for Disease Control and Prevention, Atlanta. In addition, serotypes were determined using conventional multiplex PCR as described by Carvalho et al. (2010) . Serotypes were subdivided into the categories of: PCV7+6A (4, 6A, 6B, 9V, 14, 18C, 19F, 23F); PCV13 minus PCV7+6A (1, 3, 5, 7F, 19A) ; and non-PCV (serotypes other than 1, 3, 4, 5, 7F, 6A, 6B, 9V, 14, 18C, 19A, 19F and 23F) .
Antimicrobial-susceptibility testing. MICs for 18 antibiotics, including the 11 depicted in Table 2 as well as vancomycin, linezolid, levofloxacin, ciprofloxacin, tetracycline, chloramphenicol and rifampicin, were determined for all 91 isolates by the broth microdilution method (CLSI, 2011) . Earlier guidelines were also used to describe parenteral penicillin-resistance phenotypes for non-meningitis cases (CLSI, 2007) . During 2007, the cut-offs for penicillin susceptibility and intermediate resistance were ¡0.06 and 0.12-1.0 mg ml 21 , respectively, with resistance at ¢2 mg ml 21 . Current guidelines have the cut-off for penicillin susceptibility at ¡2 mg ml 21 , intermediate resistance at 4 mg ml 21 and resistance at ¢8 mg ml 21 (CLSI, 2011) . The year 2011 cut-offs for 11 of these antibiotics are shown in Table 2 .
Detection of macrolide-resistance determinants. The ermB and mefA determinants were amplified as described by Waites et al. (2003) .
MLST. MLST was performed as described by Enright & Spratt (1998) with modifications (Moore et al., 2008) . The two most diverse targets (xpt and ddl) of the 7 used for MLST were amplified and sequenced from all 91 isolates. For each different serotype/two allele combination observed, the five remaining MLST alleles were determined from one to three isolates in order to assign a completed seven allele MLST identifier [sequence type (ST)] to the entire set. Eleven new STs and five new alleles were observed and submitted to the pneumococcal global MLST database (http://spneumoniae.mlst.net -accessed 26 May 2011).
RESULTS

Isolates
The age profile of the 91 patients revealed a typical twinpeak distribution, with most patients being either ,5 years or ¢50 years old Among the isolates, 25 (27.5 %) were from children aged ,2 years, 22 (24.2 %) were from those aged 2-4 years, 9 (9.9 %) were from those aged 5-15 years, 10 (10.9 %) were from patients aged 16-49 years and 25 (27.5 %) were from patients aged ¢50 years.
Serotype distribution
A total of 20 different serotypes were found among 90 of the 91 isolates by employing the Quellung reaction (one isolate was nontypable). The overall distribution, in order of serotype frequency, is shown in Table 1 . The 6 most frequently recovered serotypes were the PCV13 serotypes 19F (32 isolates), 19A (9 isolates), 6B (9 isolates), 23F (7 isolates), 14 (6 isolates) and 6A (4 isolates), which together accounted for 67 of the 91 isolates (73.6 %). Two remaining PCV13 isolates were serotype 1. The three classes of serotypes (PCV7+6A, PCV13 minus PCV7+6A and non-PCV) were fairly evenly distributed between the two halves of this study subdivided according to age (,5 years and ¢5 years) ( Fig. 1 ). All five sterile site isolates were from individuals 5 years of age or older. Four of these five isolates were of PCV7 serotypes [6B (two isolates), 14 (one isolate), 19F (one isolate)], with a single non-PCV serotype isolate (35A). A total of 15 of the 20 serotypes encountered were found in children ,5, with serotypes 34, 10F, 11A, 15A, 17F and 7C exclusively recovered from 1 to 2 individuals each. Serotypes 15B, 15F, 16F and 35A were recovered from one to two individuals each of ages 14 years or older.
Conventional Quellung-based serotyping compared to PCR-based serotyping
A total of 90 of the 91 isolates were serotyped using the Quellung-based methodology ( Table 1 ). The single Quellung-nontypable isolate yielded a complex multifactor Quellung result and non-specific banding with multiplex PCR. Although we cannot presently interpret these results from this isolate, they are possibly indicative of a newly encountered serotype. A total of 88 of the 91 isolates were PCR-serotypable. The two remaining PCR-nontypable isolates were typed as 33C using the Quellung reaction and yielded no bands using the PCR assay (Table 1) .
Antimicrobial resistance
Susceptibility testing of the 91 isolates for 18 different antibiotics showed that with the exception of 2 strains, all were resistant to 2 or more antibiotics (Table 2, Fig. 2 ). All isolates were sensitive to vancomycin, linezolid, levofloxacin and telithromycin. Two isolates were rifampicin resistant (data not shown). Nearly all of the isolates were resistant to both erythromycin and clindamycin (97.8 %), with the exception of single isolates of 10F and 23F that were susceptible to both antibiotics. In addition, the majority (67, 73.6 %) of the isolates were nonsusceptible to at least one of the b-lactam antibiotics (BLAs) penicillin, amoxicillin, cefuroxime, ceftriaxone or meropenem. Fortynine isolates (53.9 %) were penicillin nonsusceptible by current Clinical and Laboratory Standards Institute (CLSI) MIC breakpoints for non-meningitis isolates (40 were intermediately resistant with MICs of 4 mg ml 21 , 9 were resistant with MICs ¢8 mg ml 21 ) (CLSI, 2011). Of the 24 isolates displaying complete susceptibility to BLAs, only 6 were of PCV13 serotypes, including 2 each of serotypes 1, 6B and 19F. Only 4 of the 67 BLA-nonsusceptible isolates were not of PCV13 serotypes. These included four serogroup 15 isolates encompassing serotypes 15A (one isolate), 15B (two isolates) and 15C (one isolate). Notably, two of these isolates (15B and 15C) displayed resistance according to current breakpoints (CLSI, 2011) to different combinations of BLAs (the 15B isolate resistant to all five BLAs, the 15C isolate fully resistant to all except for penicillin (intermediate resistance) and cefotaxime (MIC51 mg ml 21 ).
Genotyping data
We assigned STs to all 91 isolates based upon serotypes, partial MLST profiles and complete MLST performed upon DNew STs found during this study are indicated in bold. Partial MLST (xpt+ddl) was performed upon all isolates and was used to group isolates sharing the same antimicrobial-susceptibility pattern into sets. From these sets, the indicated number of random isolates were picked to determine the entire seven locus profile. (983, 3263, 5244, 876, 3173, 6555, 3397, 6202, 2296, 4661, 6739, 2291, 2758, 6542 and 5893) , with the remaining STs representing major internationally disseminated clones (STs 271, 320, 90, 81, 242) , STs identical or closely related to STs solely recorded from developed western countries (STs 4112, 6738, 6544 and 3214), or to ST3751 found in Egypt (STs 3751 and 6578).
Macrolide-determinant distribution
All 88 isolates that were resistant to both clindamycin and erythromycin contained the ermB determinant ( Table 2) . The 30 ST271 serotype 19F isolates together with the 9 closely related ST320 (single locus variant of ST271) serotype 19A isolates additionally contained the mefA determinant. In addition, two other strains resistant to both antibiotics were positive for both mefA and ermB in addition to the ermB determinant. These included the single serotype 7C ST6337 isolate and the single serotype 35A ST3214 isolate. The three erythromycin-sensitive isolates (23F/ ST242 and 10F/ST6338) lacked both determinants. 
Multiresistance
Only two strains (23F/ST242 and 10F ST6338), accounting for three isolates, were not resistant to multiple antibiotics ( Table 2) . The remaining 28 strains, accounting for 88 isolates, were fully resistant to 2 or more antibiotics. A total of 6 strains, defined by serotype and ST, that encompassed 58 of the 91 total isolates (64 %) exhibited resistance to 6 or more antibiotics. These included 19F/ST271, 19A/ST322 and 15C/ST6555 (nine resistances each); and three additional strains with six to seven resistances (6B/ST90, 14/ ST876 and 23F/ST81). Two isolates of strain 19F/ST271 were additionally resistant to rifampicin (data not shown).
DISCUSSION
From this small collection of 91 clinical pneumococcal isolates recovered in a Chinese hospital during an approximately 1 year period, we found that about 76 % were PCV13 serotypes and mainly of globally predominant strains. The majority of PCV13 serotype isolates (59/69, 86 %) were resistant to at least 4 different antibiotics and as many as 9 antibiotics. These representative clones (STs 271, 320, 90 and 81), with the exception of ST320/19A, were especially predominant in the pre-PCV7 period in the USA (Beall et al., , 2011 , but are currently relatively uncommon causes of invasive disease in the USA due to widespread vaccination of the paediatric population and the resultant herd-immunity effect (Pilishvili et al., 2010) .
It is well documented that pneumococcal resistance to penicillin is generally accompanied by resistance to additional classes of antibiotics. Among the 91 isolates studied in this report, 73 (80.2 %) were nonsusceptible to penicillin (MICs ¢4 mg ml 21 ), and all of these isolates were resistant to additional classes of antibiotics (data not shown). This proportion of penicillin nonsusceptibility markedly differed from that described in a recent report from China coastal population centres where only 6 of 338 respiratory specimen isolates (1.8 %) were nonsusceptible employing current breakpoints (Yao et al., 2011) . If resistance was defined by 2007 breakpoints (¢2 mg ml 21 ) (CLSI, 2007), then penicillin resistance increased to 22.2 % (compared to 70.3 % among the 91 isolates described here) (Fig. 2) . Serotype distributions described here are closely similar to the larger Chinese pneumococcal strain surveillance study (Yao et al., 2011) , where serotypes 19F, 19A, 23F, 6B and 14 were most common and also accounted for most penicillin nonsusceptibility. Consistent with this previous study, nearly all isolates characterized in our study were also erythromycin resistant. The high erythromycin MICs combined with resistance to clindamycin was consistent with the observation that all of these isolates contained the ermB determinant that confers resistance to macrolides, lincosamides and streptogramin B through a ribosomal methylation mechanism. In agreement with previous results found from geographically widely separated isolates of the 19F ST271 clone and the closely related 19A ST320 clone, the 30 ST271 19F isolates and 9 ST320 19A isolates from our study carried the mefA macrolide-efflux determinant in addition to ermB (Moore et al., 2008; Tarragó et al., 2011; Toltzis et al., 2006) .
There are limitations to this study. The high proportion of highly antimicrobial-resistant pneumococcal isolates recovered is consistent with common prior antibiotic use within the general area serviced by this hospital. Antibiotics are widely available without prescription in China (Yao et al., 2011; Zhang et al., 2006) , so it is likely that antibiotic-susceptible strains were under-represented in our survey. It is also likely that many of the specimens were collected after antibiotics were given to the patients in the hospital. The majority of these isolates were recovered from sputum specimens, which can result in the recovery of carriage strains not associated with disease.
Although the majority of isolates characterized in this study represented a small subset of well-characterized, globally disseminated pathogenic clones, many of the individual multilocus sequence types had only been documented within Asian countries. It was interesting to note the presence of ST876 among the highly resistant serotype 14 isolates in this study and primarily associated in the global database from other Chinese type 14 isolates (pneumococcal MLST database -http://spneumoniae.mlst. net -accessed 26 May 2011). ST876 is a single locus variant of ST199, which accounts for a large fraction of USA serotype 19A isolates that are typically penicillin-intermediate or susceptible (by 2007 CLSI breakpoints; CLSI, 2007) (Moore et al., 2008; Beall et al., 2011) . We and another group from Spain have recently reported the association of ST876 with invasive serotype 19A isolates that are relatively antimicrobial sensitive and have low MICs (0.12 mg ml 21 ) for penicillin (Moore et al., 2008; Tarragó et al., 2011) .
Many of the genotypes found among these study isolates were restricted only to strains recovered in China and other geographical locations where pneumococcal genotyping has been limited (Table 1) . This provided an opportunity to further demonstrate the utility of PCR-based serotyping with a new and genetically diverse set of strains. At the current time, only a relatively small fraction of geographical areas have been assessed by PCR-based serotyping, so the possibility remains that there is significant sequence variation within cps gene targets that could conceivably confound efforts to PCR-serotype diverse pneumococcal isolate sets. Of the 91 isolates characterized here, only 3 were not PCR serotypable. These included one isolate that was accurately found to be nontypable (corresponded to a Quellung-nontypable isolate) and also corresponded to two type 33C isolates. Although the current sequential multiplex PCR assay we employ includes 40 different serotypes commonly found among disease and carriage pneumococcal isolates, serotype 33C is not included (Carvalho et al., 2010) .
Although serotype 19A IPD, due to genotypes ST320, ST199 and other genotypes, significantly emerged in the USA during the post-PCV7 era (Beall et al., 2011) , PCV7 implementation has still decreased pneumococcal disease by greater than 80 % in the vaccinated population (Pilishvili et al., 2010) . The work presented here, as well as other recent serotype distribution data (Yao et al., 2011) , suggests that PCV7 would greatly decrease resistant pneumococcal disease within China, and that PCV13 would provide a substantially greater benefit, primarily through targeting disease caused by ST320 serotype 19A.
